Get started
Work

Supplemental table S1 from The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors

Year: 2023
Type: supplementary-materials
Abstract: Ibrutinib significantly sensitizes ABCB1-overexpressing cells to vincristine and colchicine.
DOI: 10.1158/1535-7163.22503117.v1
Authors: Hui Zhang, Atish Patel, Yi-Jun Wang, Yun-Kai Zhang, Rishil J. Kathawala, Long-Hui Qiu, Bhargav A. Patel, Li-Hua Huang, Suneet Shukla, Dong-Hua Yang, Suresh V. Ambudkar, Li-Wu Fu, Zhe-Sheng Chen
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362484841
Cites:
Cited by:
Related to: 10